Literature DB >> 3999940

Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates.

W R Couet, R C Brasch, G Sosnovsky, T N Tozer.   

Abstract

Because of their paramagnetic properties, nitroxides are potentially useful as contrast agents in magnetic resonance imaging (MRI). They are reduced in vivo to their corresponding hydroxylamines which are nonparamagnetic and have no contrast enhancing property. Nitroxides with high resistance to reduction would be advantageous as pharmaceutical contrast enhancing agents. We show that in the presence of ascorbic acid and in tissue homogenates, the reduction is faster for piperidine than for pyrrolidine nitroxides and for positively-charged than for negatively-charged derivatives. The data also suggest that nitroxide reduction in tissue homogenates is mainly due to sulfhydryl groups on proteins and that endogenous ascorbic acid plays a relatively minor role.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3999940     DOI: 10.1016/0730-725x(85)90012-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  18 in total

1.  Heterogeneity of regional redox status and relation of the redox status to oxygenation in a tumor model, evaluated using electron paramagnetic resonance imaging.

Authors:  Keizo Takeshita; Kumiko Kawaguchi; Kaori Fujii-Aikawa; Megumi Ueno; Shoko Okazaki; Mitsuhiro Ono; Murali C Krishna; Periannan Kuppusamy; Toshihiko Ozawa; Nobuo Ikota
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

Review 2.  New NMR tools for protein structure and function: Spin tags for dynamic nuclear polarization solid state NMR.

Authors:  Rivkah Rogawski; Ann E McDermott
Journal:  Arch Biochem Biophys       Date:  2017-06-13       Impact factor: 4.013

3.  Dynamic Nuclear Polarization Signal Enhancement with High-Affinity Biradical Tags.

Authors:  Rivkah Rogawski; Ivan V Sergeyev; Yongjun Li; M Francesca Ottaviani; Virginia Cornish; Ann E McDermott
Journal:  J Phys Chem B       Date:  2017-02-06       Impact factor: 2.991

4.  Stability of nitroxide biradical TOTAPOL in biological samples.

Authors:  Kelsey M McCoy; Rivkah Rogawski; Olivia Stovicek; Ann E McDermott
Journal:  J Magn Reson       Date:  2019-04-22       Impact factor: 2.229

5.  Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical.

Authors:  Atsushi Ueda; Sohji Nagase; Hidekatsu Yokoyama; Mika Tada; Hiroyuki Noda; Hiroaki Ohya; Hitoshi Kamada; Aki Hirayama; Akio Koyama
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

6.  Singlet oxygen production in thylakoid membranes during photoinhibition as detected by EPR spectroscopy.

Authors:  E Hideg; C Spetea; I Vass
Journal:  Photosynth Res       Date:  1994-02       Impact factor: 3.573

7.  Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape.

Authors:  Ryan M Davis; Shingo Matsumoto; Marcelino Bernardo; Anastasia Sowers; Ken-Ichiro Matsumoto; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

8.  Deletion of UCP1 enhances ex vivo aortic vasomotor function in female but not male mice despite similar susceptibility to metabolic dysfunction.

Authors:  Nathan C Winn; Zachary I Grunewald; Michelle L Gastecki; Makenzie L Woodford; Rebecca J Welly; Stephanie L Clookey; James R Ball; T'Keaya L Gaines; Natalia G Karasseva; Jill A Kanaley; Harold S Sacks; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

9.  In vivo measurement of tumor redox environment using EPR spectroscopy.

Authors:  Govindasamy Ilangovan; Haiquan Li; Jay L Zweier; Periannan Kuppusamy
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Antioxidant properties of MitoTEMPOL and its hydroxylamine.

Authors:  Jan Trnka; Frances H Blaikie; Angela Logan; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Res       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.